东诚药业
(002675)
| 流通市值：100.88亿 | | | 总市值：111.90亿 |
| 流通股本：7.43亿 | | | 总股本：8.25亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 755,972,381.28 | 770,179,007.66 | 861,339,732.94 | 692,351,550.96 |
| 应收票据及应收账款 | 927,454,486.75 | 938,551,532.6 | 911,819,718.6 | 832,112,402.38 |
| 其中：应收票据 | 15,041,474.93 | 9,361,054.82 | 8,335,727 | 14,349,374.55 |
| 应收账款 | 912,413,011.82 | 929,190,477.78 | 903,483,991.6 | 817,763,027.83 |
| 应收款项融资 | 8,782,652.11 | 16,747,973.85 | 12,677,498.85 | 12,826,859.69 |
| 预付款项 | 27,160,841.34 | 19,237,846.54 | 23,587,068.84 | 31,427,061.21 |
| 其他应收款合计 | 12,486,659.78 | 10,724,895.16 | 8,408,602.03 | 13,639,434.49 |
| 应收股利 | - | - | - | 2,928,000 |
| 存货 | 646,221,273.48 | 635,729,750.03 | 733,044,932.71 | 885,409,734.03 |
| 一年内到期的非流动资产 | 3,374,653.98 | 1,503,259.17 | 860,186.07 | 2,845,960.85 |
| 其他流动资产 | 37,654,028.35 | 55,433,523.55 | 79,094,089.5 | 77,976,380.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,567,648,523.38 | 2,633,124,956.35 | 2,741,387,566.71 | 2,698,589,383.96 |
| 非流动资产: | | | | |
| 债权投资 | 38,568,709.29 | 36,895,678.23 | 36,810,496.99 | 7,609,144.5 |
| 长期应收款 | 1,520,945.92 | 3,251,775.06 | 4,720,864.73 | 4,189,605.79 |
| 长期股权投资 | 211,285,607.8 | 211,201,976.69 | 223,188,145.77 | 227,484,270.9 |
| 其他权益工具投资 | 106,200,000 | 106,200,000 | 106,200,000 | 107,514,983.75 |
| 投资性房地产 | 19,831,354.59 | 96,119.13 | 96,119.13 | 96,119.13 |
| 固定资产 | 1,730,899,116.52 | 1,406,613,630.01 | 1,417,042,309.33 | 1,410,745,092.57 |
| 在建工程 | 567,907,007.76 | 870,224,137.96 | 780,118,261.7 | 749,007,667.02 |
| 使用权资产 | 36,091,555.28 | 12,220,026.23 | 14,600,146.31 | 15,704,005.47 |
| 无形资产 | 252,539,244.52 | 211,829,531.41 | 209,104,227.16 | 213,587,701.07 |
| 开发支出 | 265,690,610.52 | 305,243,842.39 | 279,254,441.89 | 238,360,967.99 |
| 商誉 | 2,500,809,824.61 | 2,542,387,276.94 | 2,549,742,647.92 | 2,547,778,847.27 |
| 长期待摊费用 | 97,332,150.33 | 47,710,545.12 | 36,486,298.25 | 36,268,850.98 |
| 递延所得税资产 | 94,889,299.71 | 78,676,372.88 | 74,165,773.4 | 80,688,261.81 |
| 其他非流动资产 | 143,464,046.21 | 178,234,282.61 | 195,969,911.53 | 191,554,659.25 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,067,029,473.06 | 6,010,785,194.66 | 5,927,499,644.11 | 5,830,590,177.5 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,634,677,996.44 | 8,643,910,151.01 | 8,668,887,210.82 | 8,529,179,561.46 |
| 流动负债: | | | | |
| 短期借款 | 448,879,586.83 | 419,838,715.95 | 493,657,239.56 | 460,845,933.46 |
| 应付票据及应付账款 | 588,406,696.41 | 580,632,949.69 | 614,912,781.28 | 689,784,632.1 |
| 其中：应付票据 | 393,667,747.52 | 410,240,559.64 | 445,468,494.31 | 517,333,107.27 |
| 应付账款 | 194,738,948.89 | 170,392,390.05 | 169,444,286.97 | 172,451,524.83 |
| 预收款项 | 376,957.75 | 7,799.9 | 324,865.31 | 331,852.4 |
| 合同负债 | 105,632,249.25 | 117,979,735.43 | 123,174,934.61 | 120,277,267.15 |
| 应付职工薪酬 | 116,490,184.61 | 96,017,731.06 | 87,912,090.5 | 80,292,887.54 |
| 应交税费 | 70,018,035.62 | 74,172,869.02 | 69,431,748.27 | 70,941,598.04 |
| 其他应付款合计 | 330,347,243.92 | 253,970,467 | 276,869,925.95 | 273,889,277.73 |
| 其中:应付利息 | 5,160,165.99 | 5,411,074.89 | 5,365,520.34 | 5,473,109.87 |
| 应付股利 | 53,580,427.68 | 21,874,783.75 | 34,046,776.79 | 30,083,799.55 |
| 一年内到期的非流动负债 | 73,987,713.73 | 111,468,553.11 | 117,655,867.5 | 177,118,588.65 |
| 其他流动负债 | 19,817,452.6 | 8,495,397.18 | 12,145,830.99 | 19,388,882.88 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,753,956,120.72 | 1,662,584,218.34 | 1,796,085,283.97 | 1,892,870,919.95 |
| 非流动负债: | | | | |
| 长期借款 | 301,857,994.42 | 308,441,134.83 | 271,987,244.8 | 294,996,745.22 |
| 租赁负债 | 33,882,639.01 | 5,117,293.01 | 6,314,305.68 | 11,847,424.16 |
| 长期应付款 | 958,202,692.18 | 940,744,451.3 | 921,220,355.21 | 222,177,752.01 |
| 预计负债 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 |
| 递延收益 | 195,685,123.73 | 237,789,248.65 | 233,222,937.89 | 235,359,540.4 |
| 递延所得税负债 | 17,405,583.24 | 17,803,653.34 | 17,272,348.34 | 17,670,974.5 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,509,253,920.83 | 1,512,115,669.38 | 1,452,237,080.17 | 784,272,324.54 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,263,210,041.55 | 3,174,699,887.72 | 3,248,322,364.14 | 2,677,143,244.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 824,595,705 | 824,595,705 | 824,595,705 | 824,595,705 |
| 资本公积 | 1,998,256,195.26 | 1,999,160,938.53 | 2,003,409,648.94 | 2,515,668,289.56 |
| 其他综合收益 | 14,841,578.28 | 10,720,020.36 | 50,857.54 | -190,604.59 |
| 盈余公积 | 279,244,326.85 | 240,596,430.83 | 240,596,430.83 | 240,596,430.83 |
| 未分配利润 | 1,363,506,842.54 | 1,426,426,917.82 | 1,371,348,604.47 | 1,426,960,786.35 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,480,444,647.93 | 4,501,500,012.54 | 4,440,001,246.78 | 5,007,630,607.15 |
| 少数股东权益 | 891,023,306.96 | 967,710,250.75 | 980,563,599.9 | 844,405,709.82 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,371,467,954.89 | 5,469,210,263.29 | 5,420,564,846.68 | 5,852,036,316.97 |
| 负债和股东权益合计 | 8,634,677,996.44 | 8,643,910,151.01 | 8,668,887,210.82 | 8,529,179,561.46 |
| 公告日期 | 2025-02-27 | 2024-10-29 | 2024-08-31 | 2024-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |